Several studies have shown that detection of PD-L1 protein on tumour cells before treatment correlates with a positive response to checkpoint inhibitors. However, some patients who seem to be PD ...

发表了题为“TERC Suppresses PD-L1 Expression by Downregulating RNA Binding Protein HuR”的研究论文，揭示了TERC具有调控肿瘤细胞PD-L1表达水平的新功能。 癌细胞 ...

Sarah Anderson, oncology strategy lead director, Novotech, discusses the growing prominence of triple-negative breast cancer ...

Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...

DelveInsight’s Advanced Cervical Cancer pipeline report depicts a robust space with 70+ active players working to develop 75+ ...

Their work, published in the Journal of the American Chemical Society, focuses on understanding how therapeutic proteins ...

Such drugs are immune checkpoint inhibitors that block PD-1 and PD-L1 proteins that stop the body’s immune system from attacking cancer cells. They essentially disrupt the cancer cells ...